Allarity Therapeutics, Inc. Gain (Loss) on Fair Value Hedges Recognized in Earnings
Allarity Therapeutics, Inc. (ALLR) reported Gain (Loss) on Fair Value Hedges Recognized in Earnings of $9.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings · last filed 2023-03-13
- Allarity Therapeutics, Inc. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2021-12-31 was $0.00.
- Allarity Therapeutics, Inc. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2021-09-30 was $0.00.
- Allarity Therapeutics, Inc. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2021-06-30 was $3.00K.
- Allarity Therapeutics, Inc. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2021-03-31 was $6.00K.
- Allarity Therapeutics, Inc. gain (loss) on fair value hedges recognized in earnings for fiscal 2021 was $9.00K, a 0.00% change from fiscal 2020.
- Allarity Therapeutics, Inc. gain (loss) on fair value hedges recognized in earnings for fiscal 2020 was $9.00K.
| Period end | Gain (Loss) on Fair Value Hedges Recognized in Earnings 3 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 6 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 9 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 12 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 12 month as first filed |
|---|---|---|---|---|---|
| 2022-09-30 | $9.00K 10-Q · filed 2022-11-14 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | $3.00K derived: sum of 3 quarters · filed 2023-03-13 | $9.00K 10-K · filed 2023-03-13 | -$9.00K 10-K · filed 2022-05-17 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-23 | $3.00K derived: sum of 2 quarters · filed 2022-10-07 | $9.00K 10-Q · filed 2021-11-23 | ||
| 2021-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | $9.00K 10-Q · filed 2022-10-07 | |||
| 2021-03-31 | $6.00K 10-Q · filed 2022-05-27 | ||||
| 2020-12-31 | $9.00K 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |